TFS
PTLA

TrustCore Financial Services’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

TrustCore Financial Services’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-100
Closed -$1K – 986
2020
Q1 		$1K Hold
100
– – ﹤0.01% 867
2019
Q4 		$2K Hold
100
– – ﹤0.01% 843
2019
Q3 		$3K Hold
100
– – ﹤0.01% 837
2019
Q2 		$3K Hold
100
– – ﹤0.01% 818
2019
Q1 		$3K Buy
+100
New +$2.88K ﹤0.01% 745
2018
Q4 		– Sell
-100
Closed -$3K – 851
2018
Q3 		$3K Hold
100
– – ﹤0.01% 747
2018
Q2 		$4K Buy
+100
New +$3.83K ﹤0.01% 732

Other funds holding PTLA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

TrustCore Financial Services's PTLA Position: Q2 2020 in Review

TrustCore Financial Services sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2020, closing a stake of 100 shares — an estimated $1K sold.

TrustCore Financial Services first reported a position in PTLA in Q2 2018 and held it in 7 quarters. The position peaked at $4K in Q2 2018. 162 funds tracked by Wall St. Rank hold PTLA as of Q2 2020.

  • TrustCore Financial Services reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
  • TrustCore Financial Services sold 100 Portola Pharmaceuticals, Inc. shares in Q2 2020, an estimated $1K.
  • TrustCore Financial Services first reported a position in Portola Pharmaceuticals, Inc. in Q2 2018 and held it in 7 quarters.
  • TrustCore Financial Services's Portola Pharmaceuticals, Inc. position peaked at $4K in Q2 2018.
  • 162 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2020.

Based on TrustCore Financial Services's 13F filing for Q2 2020, filed 29 Jul 2020.